| 21/41 | US=84-A / Biol/Mol Piestrzeniewicz-Ulanska D, McGuinness DH, Yeaman GR. Transformig growth factor-B in developing and advanced cancers: TGF-B signaling in endometrial cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 63-78. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. CANCER ENDOMETRIAL; ENDOMETRIO; SMADS; HORMONIOS ESTEROIDES; TGF-B; TGF-B RECEPTORES |
| 22/41 | US=84-A / Biol/Mol Bartholin L, Guise T. Transformig growth factor-B in developing and advanced cancers: role of TGF-B in osteolytic bone metastases. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 95-123. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. |
| 23/41 | US=84-A / Biol/Mol Buck M, Knabbe. Transformig growth factor-B in developing and advanced cancers: hormonal regulation of transforming growth factor-B in breast cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 125-32. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. ANTIESTROGENIO; CANCER DE MAMA; ESTROGENIO; REGULACAO HORMONAL; PROGESTINA; RETINOIDE; RESISTENCIA; TGF-B |
| 24/41 | US=84-A / Biol/Mol Fukuchi M, Kato H, Kuwano H. Transformig growth factor-B in developing and advanced cancers: TGF-B and progression of esophageal cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 133-40. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. |
| 25/41 | US=84-A / Biol/Mol Todorovic-Rakovic N. Transformig growth factor-B in developing and advanced cancers: TGF-B and HER2/ErbB2 and beast cancer progression. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 141-51. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. TGF-B; HER2; CANCER DE MAMA; SMAD; RAS/MAPK; SINERGISMO; PROGRESSAO |
| 26/41 | US=84-A / Biol/Mol Becker C, Neurath MF. Transformig growth factor-B in developing and advanced cancers: TGF-B dependent T-Cell regulation in colitis and colon cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 153-66. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. TGF-B; CD25; COLITE; CANCRO DO COLON; TREG; FOXP3; CELULA T; REGULACAO |
| 27/41 | US=84-A / Biol/Mol Wolfrain LA, Letterio JJ. Transformig growth factor-B in developing and advanced cancers: perturbations of TGF-B signaling in leukocytes as drivers of leukemogenesis and epithelial tumorigenesis. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 181-202. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. FATOR TRANSFORMADOR DE CRESCIMENTO - B; TGF-B; SMAD; LEUCEMOGENESE; CELULAS T; IMUNOTERAPIA TUMOR; MODELOS DE RATO; ESTROMA; LINFOCITOS EPITELIAIS INTERACCOES |
| 28/41 | US=84-A / Biol/Mol Vivien D, Benchenane K, Ali C. Transformig growth factor-B in developing and advanced cancers: transforming growth factor-B in brain functions and dysfunctions. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 203-18. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. |
| 29/41 | US=84-A / Biol/Mol Yasui H, Hideshima T, Anderson KC. Transformig growth factor-B in developing and advanced cancers: inhibition of TGF-B signaling in multiple myeloma and its bone marrow microenvironment. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 219-27. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. TGF-B; IL-6; VEGF; TGF-B RECEPTOR TIPO I; TBRI; MIELOMA MULTIPLO; MICROAMBIENTE DA MEDULA OSSEA; FATOR TRANSFORMADOR DE CRESCIMENTO; FACTOR DE CRESCIMENTO ENDOTELIAL VASCULAR; INIBIDOR DE QUINASE SD-208 |
| 30/41 | US=84-A / Biol/Mol Bollard CM, Rooney CM. Transformig growth factor-B in developing and advanced cancers: role of in tumor protection and antitumor immunity. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 383-400. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. TGF-B; CTL; TGF-B RECEPTORES; TGFBRI; TGFBRII; TGFBRIII; IMUNOTERAPIA; CANCER; FATOR TRANSFORMADOR DE CRESCIMENTO - B; LINFOCITO T CITOTOXICO |
| 31/41 | US=84-A / Biol/Mol Lee C, Shah A, Liu VC, Park II, Wong LY, Huang X, Huang L, Zhou VW, Medler T, Kundu SD, Zhang Q, Smith ND. Transformig growth factor-B in developing and advanced cancers: adoptive transfer of tumor reactive TGF-B insensitive CD8 T cellss for cancer therapy. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 443-61. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. TUMOR DERIVADO DE TGF-B; VIGILANCIA IMUNE; TGF-B; TGF-B INSENSIVEIS CD8 + CELULAS-T; A TRANSFERENCIA ADOPTIVA DE CELULAS CD8 + CELULAS-T; ERRADICACAO DO TUMOR |
| 32/41 | US=84-A / Biol/Mol Pardali E, Liu Z, Scharpfenecker M, Dijke P. Transformig growth factor-B in developing and advanced cancers: TGF-B signaling and vascular morphogenesis. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 507-21. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. TGF-B; HHT; ANGIOGENESE; ENDOGLINA; HHT; TRANSDUCAO DE SINAL |
| 33/41 | US=84-A / Biol/Mol Dennler S, Mawviel A, Verrecchia F. Transformig growth factor-B in developing and advanced cancers: TGF-B and stromal influences over local tumor invasion. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 537-51. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. |
| 34/41 | US=84-A / Biol/Mol McCartney-Francis NL, Wahl SM. Transformig growth factor-B in developing and advanced cancers: TGF-B at the crossroads between inflammation, suppression and cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 553-70. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. TUMORIGENESE; TREG; SUPRESSAO; TGF-B; LINFOCITOS T; MACROFAGOS |
| 35/41 | US=84-A / Biol/Mol Datta PK, Mann JR. Development of inhibitors of transforming growth factor-B signaling for therapy: transforming growth factor-B (TGF-B) signaling inhibitors in cancer therapy. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 573-87. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. TGF-B; PEQUENA MOLECULA INIBIDORES; TRANSDUCAO DE SINAL; SUPRESSOR DE TUMOR; PROMOTOR DE TUMOR; BIOMARCADOR; TERAPIA DO CANCER |
| 36/41 | US=84-A / Biol/Mol Schlingensiepen KH, Jachimczak P, Fischer-Blass B, Fischer D, Specht H, schmaus S, Schlingensiepen R. Development of inhibitors of transforming growth factor-B signaling for therapy: targeted downregulation of TGF-B2 with AP 12009 in tumor therapy. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 635-51. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. OLIGODEOXINUCLEOTIDOS ANTISENSE; CANCER; GLIOMA MALIGNO; TGF-B; USO TERAPEUTICO |
| 37/41 | US=84-A / Biol/Mol Naumann U, Weller M. Development of inhibitors of transforming growth factor-B signaling for therapy: modulating TGF-B receptor signaling: a novel approach of cancer therapy. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 653-69. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. TGF-B; TGF-B RECEPTORES; MOLECULAS PEQUENAS; DOMINANTE NEGATIVO; RECEPTOR SOLUVEL |
| 38/41 | US=84-A / Biol/Mol Ling LE, Singh J, Chuaqui CE, Boriack-Sjodin PA, Corbley MJ, Lepage DJ, Silverio EL, Sun L, Papadatos JL, Shan F, Pontz T, Kam Cheung H, Zhang X, Arduini RM, Mead JN, Newman MN, Bowes S, Josiah S, Lee WC. Development of inhibitors of transforming growth factor-B signaling for therapy: the use of virtual screening in ALK5 kinase inhibitor discovery and validation of orally active ALK5 kinase inhibitors in oncology. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 685-96. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. VIRTUAL; FARMACOFORO; INIBIDOR DE CINASE; ALK5; TGF-B RECEPTOR TIPO I; CRISTALOGRAFIA DE RAIOS X; TGF-B |
| 39/41 | US=84-A / Biol/Mol Suzuki E, Albelda SM. Development of inhibitors of transforming growth factor-B signaling for therapy: soluble type II transforming growth factor-B receptor inhibits tumorigenesis by augmenting host ntitumor immunity. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 697-706. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. TGF-B; IMUNIDADE ANTITUMORAL; MESOTELIOMA MALIGNO; SOLUVEL DO TIPO II DO RECEPTOR DE TGF-B |
| 40/41 | US=84-A / Biol/Mol Bandyópadhyay A, Sun L. Development of inhibitors of transforming growth factor-B signaling for therapy: soluble TGF-B type III receptor suppresses malignant progression of human cancer cells. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 723-35. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. ANGIOGENESE; METALOPROTEINASE DE MATRIZ-9; METASTASE PULMONAR; METASTASE OSSEA; BETAGLICAM SOLUVEL; TGF-B; TGF-B TIPO DE INIBIDORES DO RECEPTOR III; TUMORIGENESE |